The aim of this study is to evaluate the ovarian morphological findings in infertile women given the diagnosis of polycystic ovarian syndrome (PCOS) based on chronic anovulation (menstrual disorders) and evidence of hyperandrogenism (hirsutism & acne), and whether clinical and selected hormonal findings correlate with ovarian volume. Over 12 months period (from 1st of Jan 2005 till the 1st of Jan 2006), the ovarian morphology were determined by transabdominal ultrasound in107 patients included in this prospective study in infertility clinic in Basrah Maternity and Child Hospital. Clinical and endocrinological state was evaluated by history, physical examination and measurements of serum testosterone, Luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactine and progesterone levels. Their ages ranged (18-40 years), mean (27.28 ± 4.4) and their mean body mass index (BMI) was (29.77± 4.0 kg/m2). Ultrasound studies showed all women studied (100%) had altered ovarian morphology (both ovaries had multiple small cyst of (2-9mm), mean total follicular number (12.3±1.7) & thick capsule. Bilaterally enlarged ovaries were found in 84 (78.5%), mean (15.6± 2.04 cm 3 ) and normal ovarian size were found in 23(21.5%) mean (6.6± 1.1 cm 3 ). All patients who had enlarged ovaries were compared with those who had normal ovarian size regarding clinical and hormonal findings in order to determine a possible association between these findings and ovarian volume. Hirsutism was present in (78.5%), acne in (68.2%), Obesity (BMI>25 kg/m 2 ) in (87.8%), menstrual disorders in (100%), manifested as oligomenorrhoea in (77.6%) and secondary amenorrhea in (22.4%). Comparing these clinical findings between patient who had enlarged ovaries and those who had normal ovarian size, this study has confirmed that hirsutism, acne and obesity were significantly higher in women who had enlarged ovaries the values were: (84.5% versus 56.5%), (73.8 %versus 47.8%) and( 92.9% versus 69.6%) respectively, whereas oligomenorrhoea occurred more frequently in women with normal ovarian size (82.6% vs. 76.2%), the difference was statistically non significant p.value>0.05. No significant relationship was found between ovarian volume and amenorrhea. Analysis of biochemical data showed that women with PCOS were found to have elevated Serum testosterone levels (1.3±0.74ng/ml ), elevated LH (11.80 ± 4.2 miu/ml ) and elevated LH/FSH ratio (1.90 ± 1.03) whereas all women were found to have normal prolactin levels (10.8 ± 4.0ng/ml). Comparing these hormonal levels between women who had enlarged ovaries and those who had normal-sized ovaries we found that serum testosterone, LH & LH/FSH ratio were significantly higher in women who had enlarged ovaries. Subtle differences existed between ovarian volume in hypretestosteonemic & hyperluteinizenemic subgroups of polycystic ovarian syndrome compared to normotestosteronemic & normoluteinizenemic ones. With significant relationship was found between the ovarian size and testosterone & LH levels p. value< 0.05. A significant differences also existed between ovarian volume in elevated LH/FSH ratio subgroup of polycystic ovarian syndrome compared to normal LH/FSH ratio ones. P. value 0.001. Whereas no statistical significant difference was found between ovarian volume and FSH levels. Hirsutism, acne and obesity correlated positively with total ovarian volume (r=0.282, pvalue 0.002), (r=0.229, p-value 0.009) (r=0.372, p. value 0.0001) respectively. While Oligomenorrhoea and amenorrhea showed negative correlations with total ovarian volume. Total ovarian volume correlated positively with Serum testosterone levels, LH and LH/FSH>2, (r=0.518, (r=0.563, (r=0.266, respectively. It can be concluded from the present study that ultrasound scanning provide a non-invasive and accurate procedure for the assessment of ovarian morphology (specifically ovarian volume).
) in (87.8%), menstrual disorders in (100%), manifested as oligomenorrhoea in (77.6%) and secondary amenorrhea in (22.4%). Comparing these clinical findings between patient who had enlarged ovaries and those who had normal ovarian size, this study has confirmed that hirsutism, acne and obesity were significantly higher in women who had enlarged ovaries the values were: (84.5% versus 56.5%), (73.8 %versus 47.8%) and( 92.9% versus 69.6%) respectively, whereas oligomenorrhoea occurred more frequently in women with normal ovarian size (82.6% vs. 76.2%), the difference was statistically non significant p.value>0.05. No significant relationship was found between ovarian volume and amenorrhea. Analysis of biochemical data showed that women with PCOS were found to have elevated Serum testosterone levels (1.3±0.74ng/ml ), elevated LH (11.80 ± 4.2 miu/ml ) and elevated LH/FSH ratio (1.90 ± 1.03) whereas all women were found to have normal prolactin levels (10.8 ± 4.0ng/ml). Comparing these hormonal levels between women who had enlarged ovaries and those who had normal-sized ovaries we found that serum testosterone, LH & LH/FSH ratio were significantly higher in women who had enlarged ovaries. Subtle differences existed between ovarian volume in hypretestosteonemic & hyperluteinizenemic subgroups of polycystic ovarian syndrome compared to normotestosteronemic & normoluteinizenemic ones. With significant relationship was found between the ovarian size and testosterone & LH levels p. value< 0.05. A significant differences also existed between ovarian volume in elevated LH/FSH ratio subgroup of polycystic ovarian syndrome compared to normal LH/FSH ratio ones. P. value 0.001. Whereas no statistical significant difference was found between ovarian volume and FSH levels. Hirsutism, acne and obesity correlated positively with total ovarian volume (r=0.282, pvalue 0.002), (r=0.229, p-value 0.009) (r=0.372, p. value 0.0001) respectively. While Oligomenorrhoea and amenorrhea showed negative correlations with total ovarian volume. Total ovarian volume correlated positively with Serum testosterone levels, LH and LH/FSH>2, (r=0.518, p-value 0.0001), (r=0.563, p-value 0.0001), (r=0.266, p-value 0.01) respectively. It can be concluded from the present study that ultrasound scanning provide a non-invasive and accurate procedure for the assessment of ovarian morphology (specifically ovarian volume).
Introduction
olycystic ovary syndrome (PCOS) is one of the commonest endocrinopathies affecting 5%-10% of women of reproductive age 1 . While 1t has been described as a disorder "without identity" 2 and its name is based on alteration in ovarian morphology, until recently, the diagnosis has been based on the findings of hyperandrogenism and chronic an ovulation 3 . At recent joint asrm/eshre consensus meeting, new guidelines for the diagnosis of PCOS have been put forth giving an important role to altered ovarian morphology 4, 5 . The finding of a polycystic ovary on ultrasound in association with either hyperandrogenism or anovulation is considered sufficient to make the diagnosis of PCOS according to the new definition 4, 5 . However, there is known variability in morphology as described by ultrasound (US). Increased ovarian size has been considered to be the most reliable criterion 6 , yet it has been reported recently that only a minority of patients with PCOS diagnosed on the basis of hyperandrogenism and chronic anovulation (National Institutes of Health criteria) 3 have increased ovarian size 7 . Classic ultrasound findings such as a dense stroma 6 , are no longer required 8 for the diagnosis of polycystic ovary according to the new definition 4,5 . Using laparotomy followed by histological confirmation, Stein and Leventhal were the first to describe the presence of polycystic ovarian morphology together with amenorrhea, hirsutism, and obesity 9 . Since then, the association between the presence of typical ovarian morphology and clinical and biochemical indices of (PCOS) has been confirmed 10 . Both LH and testosterone levels are elevated; with normal serum FSH levels 11 . This peculiar hormonal imbalance correlates positively with adverse fertility and pregnancy outcome 12 . The advent of US scanning provide a non-invasive procedure for the assessment of ovarian size, morphology and internal structure namely the follicles and stroma. Swanson et al were among the first to use high -resolution realtime ultrasound (static B -scanner, 3.5 MHz, Tran abdominal) to describe the ultrasound ovarian volume enlargement associated with PCOS 13 . Adams et al refined the ultrasound diagnosis of PCO to include follicular number and stroma characteristics. The typical polycystic pattern was defined by the presence of > 10 cysts measuring 2-8 mm in diameter arranged peripherally around a dense core of stroma or scattered throw an increased amount of stroma 14 . Ultrasound finding of polycystic ovaries in the general population is in the order of (17-22%) 15 and in women with anovulation and idiopathic hirsutisim is much higher (90%) 16 . Although several US features such as ovarian volume and stromal hypertrophy 17 and increased stromal blood flow 18 . Have been shown to correlate accurately with PCOS, correlations between the degree of ultrasound morphological changes and the severity of the endocrinopathy in women with PCOS has not been extensively investigated 19 25 . Basal serum testosterone levels, LH, FSH, & prolactin were assessed on day 3 of the cycle in the same hospital laboratory and read by the same person. Testosterone concentrations were measured by radioimmunoassy. The intra-assay variation was <4% and the inter-assay variation were <11%, results are expressed as ng /mL. Serum LH and FSH concentrations were measured by means of conventional immunodiometric assay. The intra-assay variation was < 5 % and the inter-assay was < 8%, results are expressed as miu/mL. A raised serum testosterone level, LH level, FSH level and PRL were defined as > 0.9ng /mL, > 8miu / mL, > 12miu/ mL and > 20ng/mL respectively. As these values were the upper limits of the normal reference range of our local laboratory. LH / FSH ratio was estimated and raised ratio was defined a > 2 23 . Ovulation was confirmed by serum progesterone levels measurement on day twenty first of the cycle. Ovulation was considered satisfactory when serum progesterone measurements were > 30 nmol / L in two successive cycles 26 . Ultrasound assessment: In all patients ovarian volume and morphology were determined by single experienced sonographer, using 3.5 MHz -curved array Linear scanner( trans abdominal ultrasound )on the same day as hormonal measurement were taken. After visualization of the ovaries with the use of a full bladder technique, the following sonographic findings were recorded: 1-Ovarian volume was calculated by the formula for a prolate ellipsoid: (1/2 x length x width x thickness) 27 . 2-Total number, diameter and distribution of the cystic structures per ovary were counted and recorded in mm. 3-Ovarian capsule, whether thick or thin. Polycystic ovarian morphology was diagnosed when there were >10 follicles with diameter 2-9 mm arranged peripherally or scattered throughout an echo dense stroma and thick capsule 15 
Results
One hundred seven women were included in this study. Their ages range from18-40 years, mean (27.28 ± 4.4 years) & mean BMI was (29.77 ± 4.00 kg /m2). (Table. I) All women with menstrual dysfunction had a withdrawal bleed within 2-7days after completing the progestational agent course. The ultrasound appearance of the ovaries is illustrated in (Table II) . The ovaries showed characteristic polycystic morphology. Mean total ovarian volume was (13.6 ± 4.1cm3) and the mean total follicular number (12.3 ±1.7mm). Both ovaries were enlarged in 84 (78.5%) with a mean ovarian volume of (15.6 ± 2.04 cm3). The ovaries were of normal size in 23 (21.5%). with a mean ovarian size of (6.6 ± 1.1cm3). All polycystic ovaries were found to have thick capsule. The mean total follicular numbers were (13.6 ± 1.2mm) in women with enlarged ovarian size and (11.2±0.7mm) in women with normal ovarian size. There was no statistical significant difference were obtained between the mean ovarian volume of right and left ovaries in women with PCOS. (Table III) The clinical features are presented in (Table IV) (Table IV) . Biochemical indices are illustrated in (Table V) 
Discussion
This study is one of few reports on the accuracy of US diagnosis of polycystic ovaries that were confirmed by clinical and hormonal findings. It has determined the prevalence of abnormal ovarian findings in 107 women when the diagnosis of PCOS is made clinically. In addition to that, identification a possible association between clinical findings and selected hormonal concentrations and ovarian volume were determined. In this study, we found that altered ovarian morphology occur in all women with clinical diagnosis of PCOS. Our findings are close to study done by Eneico et al 30 . After calculation the ovarian volume, we found 78.5% of women had increased ovarian size while 21.5% were found to have normal ovarian volume, but with classical ovarian findings on US (Table II) . Our results are close to that reported by 28, 31 . It is interesting that in creating the new criteria for the diagnosis of PCO, the consensus panel did not find the classical appearance of follicle distribution and increased stromal mass to be necessary for the diagnosis 8 . Although other investigators have stressed the importance of increased ovarian stroma, or the ratio of stroma / total area 32 , the consensus panel stated that this is reflected in total volume determinations volume determinations 8 . Because the peripherial orientation of cystic structures is not a criterion for the diagnosis for the current diagnosis 4, 5, 8 , but was necessary for our diagnosis of the classical PCO 16 so it is quite possible that our findings, none of women studied having "normal ovarian morphology".
In the present study the clinical features in women with PCOS were evaluated and we found all women with PCOS presented with anovulatary infertility. Our finding is higher than that of kosta et al 25 . In this study, hirsutism and acne were present in (78.5%) and (68.2%) of patients respectively. Our results were higher than that reported by 33, 34 . When comparing these clinical findings in women who had enlarged ovaries with those who had normal-sized ovaries, we found hirsutism and acne were higher in women who had enlarged ovaries (Table IV) . The differences were statistically significant and in agreement to that reported by 27, 31, 35 . Another finding in our study, obesity has been proven to be important and common clinical findings. It was present in (87.8%) of patients. This result is in agreement to that of 35, 36 . A higher significant relationship of obesity was found in women who had enlarged ovaries in comparison to women with normal ovarian size. Our result is in agreement to that of 27 . Menstrual disorder is another main clinical presentation, was also evaluated in our study. Approximately (77.6%) of patients presented with Oligomenorrhoea. Our result is similar to that of 37 . The prevalence of oligomenorrhoea was higher among women who had normalsized ovaries compared with women who had enlarged ovaries (Table  IV) .The difference was statistically non significant and in agreement with other studies 27, 33 .Amenorrhoea was present in( 22.4%) of women with PCOS, our finding is higher than that of 35 . In this study a higher non significant percentage of secondary amenorrhoea was found among women who had enlarged ovaries (23.8%) in comparison to those women with normal sized ovaries (17.4%).Our results are in agreement to that of 27 Biochemical data was also analyzed in our study. Serum testosterone levels & LH were elevated in women with PCOS. Our finding is in agreement to that of 30, 31, 33, 36 . In this study, we documented that women who had enlarged ovaries had higher mean serum testosterone levels compared with women who had normal ovarian size (Table V) . The difference was statistically significant and in agreement with other studies 31, 29 . In this study we document that a significant differences existed between ovarian volume & serum testosterone levels. Elevated serum testosterone was found in (75%) & normal testosterone in (25%) of women who had enlarged ovaries. Whereas elevated serum testosterone levels was found in (34.8%) & normal testosterone in (65%) of women who had normal ovarian size. (Table VI) These findings are in contrast to that of 27 . Who found no significant relationship between the US ovarian volume and serum testosterone levels. Our results allow us to suggest ovarian enlargement as a marker of excessive androgen production and disturbance of menstrual cycle in PCOS. Also we reported that women who had enlarged ovaries had a higher mean serum LH levels compared with those who had normal-sized ovaries (Table V) . The findings are in contrast to that of 27 . In this study we also document that a significant differences existed between ovarian volume & serum LH levels. (Table  VII) . These results are in agreement to that of 12, 34 . Menstrual disorders are a characteristic feature of women with PCO. However, it is interesting that we found a negative significant correlation between total ovarian volume and oligomenorrhoea and amenorrhoea. These results are in agreement to that of 27 . The present study demonstrates that total ovarian volume had appositive correlations with serum testosterone levels, LH and LH /FSH ratio (Table  VIII) .These findings are in agreement to that of 12,30 & 34 . Hyperandrogenism is a characteristic feature of women with PCOS; however, it is expecting to find a positive significant relationship between total ovarian volume and testosterone levels, hirsutism and acne. In conclusion, we have shown that in patients with classic PCOS, enlarged ovaries are present in 78.5% & 21.5%of patients had normal ovarian volume and all of these patients, have altered ovarian morphology. Hirsutism, acne, Obesity, serum testosterone levels, serum LH and LH/FSH ratio>2 were significantly higher in women who had enlarged ovaries in comparison to those who had normal ovarian size and strongly correlated with total ovarian volume. Ovarian size >10cm 3 might be predictive of endocrine profiles in women with PCOS and the value of US studies in the assessment of ovarian volume is emphasized. I would like to thank Dr. Assal B. Shindi, Department of surgery; College of Medicine, University of Basrah and Dr. Jehhan Mageed ALMukh, Department of Microbiology, Basrah Maternity and Children Hospital. 
